Capita3
Team Portfolio News Newsletter Funding Leader Programs Connect
TeamPortfolioNewsNewsletterFundingLeader ProgramsConnect
Capita3
SUBSCRIBE TO NEWSLETTER

Featured
Capita3 March 2026 Newsletter
Mar 3, 2026
Capita3 March 2026 Newsletter
Mar 3, 2026

Supporting Minnesota's Small Businesses - Capita3 co-hosts "Business for Business" Fundraiser and announces Advisory Board

Mar 3, 2026
Capita3 Portfolio Company b.well Selected by OpenAI
Jan 8, 2026
Capita3 Portfolio Company b.well Selected by OpenAI
Jan 8, 2026

as Exclusive ChatGPT Health Partner: Major validation for Capita3 Fund I portfolio company b.well, who is powering health data connectivity for 800M+ ChatGPT users

Jan 8, 2026
From Hype to Proof: Healthcare Innovation's Inflection Year
Dec 11, 2025
From Hype to Proof: Healthcare Innovation's Inflection Year
Dec 11, 2025

2025 will be marked in history as an inflection year where healthcare innovation shifted from the hype of "digital transformation" to the truth of tangible clinical and financial outcomes.

Dec 11, 2025
Healthcare Resilience: Pioneering Innovation in Uncertain Times
Oct 17, 2025
Healthcare Resilience: Pioneering Innovation in Uncertain Times
Oct 17, 2025

Healthcare organizations are now moving beyond the hype to focus on AI applications that deliver demonstrable value and real-world impact in patient care and clinical workflows

Oct 17, 2025
Capita3 Selected for 2025 RAISE 10th Annual Global Summit
Oct 9, 2025
Capita3 Selected for 2025 RAISE 10th Annual Global Summit
Oct 9, 2025

We are honored to announce that Capita3 has been selected to attend the 2025 RAISE Global Summit! 🎉 and are grateful to the RAISE team and Selection Committee for this opportunity.

Oct 9, 2025
Announcing NextSense Smartbud Product Launch
Sep 17, 2025
Announcing NextSense Smartbud Product Launch
Sep 17, 2025

NextSense's Mission to Revolutionize Rest is Realized with the Launch of Their Cutting Edge SmartBuds

Sep 17, 2025
We Are Excited to Announce Persephone's Launch of Bloom and Thrive
Sep 15, 2025
We Are Excited to Announce Persephone's Launch of Bloom and Thrive
Sep 15, 2025

The Persephone synbiotic represents a paradigm shift in infant care, featuring two proprietary Bifidobacterium infantis strains plus supporting species, paired with breast milk sugars proven to fuel bacterial colonization.

Sep 15, 2025
Capita3's Latest Investments Support Portfolio Growth
Sep 8, 2025
Capita3's Latest Investments Support Portfolio Growth
Sep 8, 2025

We are pleased to announce that we have recently completed follow on investments in portfolio companies Claros and MDisrupt. These latest financing rounds are focused on supporting rapid growth.

Sep 8, 2025
Announcing Flourish Care: Advancing Maternal Care With 1 on 1 Doula Support
Jul 31, 2025
Announcing Flourish Care: Advancing Maternal Care With 1 on 1 Doula Support
Jul 31, 2025

Flourish Care taps into an opportunity that has largely remained overlooked in the medical community: tech-enabled doula services for maternal care.

Jul 31, 2025
Kathy Tune is Named "Top 25 in ’25" by Women in Technology Investing Kayo Conference Series
Jul 1, 2025
Kathy Tune is Named "Top 25 in ’25" by Women in Technology Investing Kayo Conference Series
Jul 1, 2025

Kathy’s inclusion on this distinguished list is a testament to her track record of success as a venture capital investor, her outstanding leadership, and her commitment to innovation in the technology investment landscape.

Jul 1, 2025
Capita3 May 2025 Update  Chaos Creates Opportunity
May 29, 2025
Capita3 May 2025 Update Chaos Creates Opportunity
May 29, 2025

Chaos and uncertainty are our words of the moment. Despite these turbulent conditions, we're witnessing remarkable resilience in women's health technologies and solutions addressing the care economy.

May 29, 2025
Capita3 Invests in NextSense
May 21, 2025
Capita3 Invests in NextSense
May 21, 2025

NextSense is building a neurotech platform that is initially focused on sleep enhancement technologies for the growing consumer sleep tech market, The Company is addressing the need for accessible, noninvasive, and efficacious sleep monitoring and sleep enhancement solutions.

May 21, 2025
Capita3 Invests in Persephone
May 21, 2025
Capita3 Invests in Persephone
May 21, 2025

The Company is a leader in the growing field of microbiome-based medicine, which is exploring how the trillions of microorganisms in our bodies influence our health and how they might be leveraged for better medical treatments.

May 21, 2025
Capita3's April Newsletter
Apr 25, 2025
Capita3's April Newsletter
Apr 25, 2025

In this 90 day reprieve on the higher tariffs for all but China, we, like most investors, are working with our existing companies and prospective investments to understand the potential impact of tariffs…

Apr 25, 2025
Joylux's Halle Berry Featured on Oprah's Women's Health Special
Apr 7, 2025
Joylux's Halle Berry Featured on Oprah's Women's Health Special
Apr 7, 2025

Actress, Joylux investor and strategic brand partner - Halle Berry - was featured on  Oprah's special, alongside a panel of medical experts and leading voices to discuss the traditionally taboo topic of menopause…

Apr 7, 2025
Capita3's Early Spring Newsletter
Mar 7, 2025
Capita3's Early Spring Newsletter
Mar 7, 2025

2025 is already off to a great start, with groundbreaking healthcare advancements lighting up the industry…

Mar 7, 2025
Capita3 Invests in Paterna
Mar 4, 2025
Capita3 Invests in Paterna
Mar 4, 2025

Paterna Bioscienceis a biotech company focused on the rapidly growing $20B+infertility market…

Mar 4, 2025
Capita3 Invests in Carallel
Jan 23, 2025
Capita3 Invests in Carallel
Jan 23, 2025

Many of us are caregivers for our elderly parents or sick family members. If you've been a caregiver, you know the time and energy that goes into this labor of love…

Jan 23, 2025
 The Booming Caregiving Market: A Massive Untapped Opportunity
Jan 21, 2025
The Booming Caregiving Market: A Massive Untapped Opportunity
Jan 21, 2025

The care economy is one of the largest segments of care in the world. A recent report by Columbia University Mailman School of Public Health, and sponsored by Otsuka says…

Jan 21, 2025
2024 Year in Review
Jan 7, 2025
2024 Year in Review
Jan 7, 2025

Our portfolio company teams have skillfully navigated the ever-shifting market landscape, fostering both growth and resilience…

Jan 7, 2025
Capita3 Invests in Gabbi
Jan 6, 2025
Capita3 Invests in Gabbi
Jan 6, 2025

Gabbi is an emerging leader in breast cancer screening and detection markets, focusing on early risk assessment and care…

Jan 6, 2025
Capita3's November 2024 Newsletter
Dec 5, 2024
Capita3's November 2024 Newsletter
Dec 5, 2024

We have some initial predictions on how the new administration will impact the venture capital and healthcare industries…

Dec 5, 2024
Capita3's October Newsletter
Oct 31, 2024
Capita3's October Newsletter
Oct 31, 2024

HLTH2024, one of the largest and most important healthcare conferences of the year, took place October 20 - 23 in Las Vegas, NV….

Oct 31, 2024
Breaking Company News
Sep 24, 2024
Breaking Company News
Sep 24, 2024

Capita3 Fund II & IIA portfolio company Claros Technologies announced yesterday the completion of the first successful pilot…

Sep 24, 2024
Capita3's September Newsletter
Sep 23, 2024
Capita3's September Newsletter
Sep 23, 2024

We know that women-founded companies demonstrate 35% better returns and 2x more revenue per dollar invested than their male counterparts, yet these entrepreneurs continue to face significant challenges when raising capital…

Sep 23, 2024
Report on Recast Capital Summit
Sep 23, 2024
Report on Recast Capital Summit
Sep 23, 2024

For us, the top 2024 event was the Recast Capital Summit in Sonoma. This was a venture capital emerging manager event set in California’s wine country…

Sep 23, 2024
Generating Alpha with Venture Capital and Emerging Fund Managers
Sep 6, 2024
Generating Alpha with Venture Capital and Emerging Fund Managers
Sep 6, 2024

In the realm of asset allocation, what role do investments in venture capital funds and emerging managers play? Capita3 had the opportunity to speak with key opinion leaders in institutional asset allocation…

Sep 6, 2024
Capita3's July Newsletter
Jul 17, 2024
Capita3's July Newsletter
Jul 17, 2024

We are cautiously optimistic the liquidity market is rebounding. This optimism is balance by the election cycle, which will likely create market volatility but overall we are bullish…

Jul 17, 2024
Capita3's June Newsletter
Jun 14, 2024
Capita3's June Newsletter
Jun 14, 2024

The groundbreaking impact of AI and machine learning in advancing healthcare diagnostics is truly remarkable…

Jun 14, 2024
Capita3 Invests in Claros
May 28, 2024
Capita3 Invests in Claros
May 28, 2024

Claros Technologies, Inc. (ClarosTech™), the leader in PFAS analytical and destruction technologies, announced today that it has raised $22M

May 28, 2024

Leadership Program

© CAPITA3 2025  /  MINNEAPOLIS, MN

Hours